Ironwood Pharmaceuticals Inc., of Cambridge, Mass., reported net U.S. sales of constipation drug Linzess (linaclotide), as provided by partner Dublin-based Allergan plc, totaling $147.6 million for the first quarter, up 8 percent over the same period in 2016.